These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 12168812

  • 1. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

  • 2. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
    Majlessipour F, Kwock R, Martin-Aragon S, Weinberg KI, Avramis VI.
    Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
    [Abstract] [Full Text] [Related]

  • 3. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA, Kwock R, Avramis VI.
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [Abstract] [Full Text] [Related]

  • 4. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA, Laug WE, Sausville EA, Avramis VI.
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [Abstract] [Full Text] [Related]

  • 5. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
    Fu CH, Martin-Aragon S, Weinberg KI, Ardi VC, Danenberg PV, Avramis VI.
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
    Avramis IA, Christodoulopoulos G, Suzuki A, Laug WE, Gonzalez-Gomez I, McNamara G, Sausville EA, Avramis VI.
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Dec; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 8. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.
    Avramis VI, Nandy P, Kwock R, Solorzano MM, Mukherjee SK, Danenberg P, Cohen LJ.
    Anticancer Res; 1998 Dec; 18(4A):2327-38. PubMed ID: 9703875
    [Abstract] [Full Text] [Related]

  • 9. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
    Nandy P, Periclou AP, Avramis VI.
    Anticancer Res; 1998 Dec; 18(2A):727-37. PubMed ID: 9615712
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A, Kuriyama H, Kiyota T.
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):291-6. PubMed ID: 8712821
    [Abstract] [Full Text] [Related]

  • 11. Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
    Bassan R, Chiodini B, Zucchetti M, Lerede T, Cornelli PE, Cortelazzo S, Barbui T.
    Haematologica; 1998 Jan; 83(1):27-33. PubMed ID: 9542320
    [Abstract] [Full Text] [Related]

  • 12. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
    Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S.
    Anticancer Res; 2006 Jan; 26(1A):259-65. PubMed ID: 16475706
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 14. MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3.
    Florio S, Crispino L, Ciarcia R, Vacca G, Pagnini U, de Matteis A, Pacilio C, D'Andrilli G, Kumar C, Giordano A.
    J Cell Biochem; 2003 Jul 01; 89(4):747-54. PubMed ID: 12858340
    [Abstract] [Full Text] [Related]

  • 15. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
    Ahmed N, Laverick L, Sammons J, Zhang H, Maslin DJ, Hassan HT.
    Anticancer Res; 2001 Jul 01; 21(5):3519-23. PubMed ID: 11848518
    [Abstract] [Full Text] [Related]

  • 16. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A, Montillo M, Strocchi E, Cafro AM, Tresoldi E, Intropido L, Nichelatti M, Marbello L, Baratè C, Camaggi CM, Morra E.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):771-9. PubMed ID: 17256136
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 May 01; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH.
    Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
    Hao JH, Yu M, Liu FT, Newland AC, Jia L.
    Cancer Res; 2004 May 15; 64(10):3607-16. PubMed ID: 15150119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.